RecallDepth
Class II Ongoing

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

This recall is currently active, issued December 17, 2025. It was issued by Lupin Pharmaceuticals Inc..

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
November 13, 2025
Posted
December 17, 2025
Recall Number
D-0220-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
32736 vials
Firm Location
Naples, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Distribution

FL, MA, MI & OH

Lot / Code Info

Lot #: WB00006, Exp 12/31/2026

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls